|

Immunochemotherapy Clinical Trials

2 actively recruiting trials

Also known as: Supportive treatment

Pipeline

Phase 2: 1

Top Sponsors

  • Samsung Medical Center1
  • Peking Union Medical College Hospital1

Indications

  • Cancer2
  • Extranodal NK/T-cell Lymphoma1
  • Lymphoma1

Other2 trials

Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.